GAITHERSBURG, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS), a leader in biodefense medical countermeasures, today applauded Congress and President Bush as he signed into law the Pandemic and All-Hazards Preparedness Act, which authorizes appropriations through 2011 to improve bioterrorism and other public health emergency planning and preparedness activities and creates the Biomedical Advanced Research and Development Authority, or BARDA, under the direction of the Department of Health and Human Services, which will be focused on directing advanced research and development of vaccines and therapeutics for use against biological attacks.
